Tag: IN.PACT
Long-term IN.PACT AV data show there is “definitely a place” for...
Matteo Tozzi (Varese, Italy) and Kate Steiner (Stevenage, UK) sat down with Vascular News at this year’s Charing Cross (CX) International Symposium (23–25 April,...
IN.PACT AV Access five-year results strengthen physicians’ conviction on applying DCB...
Alexander Mallios (Paris, France) and Andrew Holden (Auckland, New Zealand; one of the co-chairs of the Charing Cross Symposium) share their views on...
Renal Interventions’ top 10 stories of February 2023
The 19th annual scientific meeting of the American Society of Diagnostic and Interventional Nephrology (ASDIN; 17–19 February, Orlando, USA) loomed large in February, with...
Experts react to “compelling” 36-month IN.PACT AV Access trial data
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Shahverdyan (Hamburg, Germany), Matteo Tozzi (Varese, Italy), Alexandros Mallios (Paris,...
Live from ASDIN: DCB or not DCB? “Compelling” evidence demands more...
The second day of the 2023 meeting of the American Society of Diagnostic and Interventional Nephrology (ASDIN; 17–19 February, Orlando, USA) played host to...
Roundtable: Will latest IN.PACT AV Access data impact practice and can...
NOTE: This video is ONLY available to watch in selected countries and geographies
In this Renal Interventions roundtable, Andrew Holden (moderator; Auckland, New Zealand) is...
First time data release: View the full IN.PACT AV Access trial...
NOTE: This video is ONLY available to watch in selected countries and geographies
In a late-breaking Podium 1st presentation at the 2022 Charing Cross...
IN.PACT AV DCB “first and only” to show sustained and superior...
Medtronic has announced new randomised controlled data demonstrating the sustained and superior performance of the IN.PACT AV drug-coated balloon (DCB) compared to percutaneous transluminal...
Medtronic issues voluntary recall for subset of IN.PACT Admiral and IN.PACT...
Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheters due to the potential...
IN.PACT AV DCB sustained “superior” effectiveness in subgroups with high reintervention...
Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB; Medtronic) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of...
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Two-year IN.PACT AV Access results presented at CX 2021
Medtronic recently announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually...
New England Journal Of Medicine publishes “outstanding” six-month IN.PACT AV Access™...
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Lookstein (New York, USA; principal investigator) and Andrew Holden (Auckland,...
IN.PACT™ AV Access trial shows improvement in patency “for the entire...
A trio of vascular experts including Raphaël Coscas (Paris, France), Alexandros Mallios (Paris, France) and Kate Steiner (Stevenage, UK) discuss the key findings of...
‘Indisputable evidence’ that DCB is the “gold standard” for treating vascular...
NOTE: This video is ONLY available to watch in selected countries and geographies
Tobias Steinke (Düsseldorf, Germany), Matteo Tozzi (Varese, Italy) and Robert Shahverdyan...